Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from GridAI Technologies ( (GRDX) ) is now available.
GridAI Technologies Corp., formerly Entero Therapeutics, Inc., entered into a Revolving Loan Agreement on January 27, 2025, with 1396974 BC Ltd., under which principal, interest, and related amounts were due in full by the January 31, 2026 maturity date. The facility provided the company with up to $700,000 in principal, and all obligations were contractually scheduled to be repaid by that date.
On April 1, 2026, the lender’s counsel sent GridAI Technologies a demand letter asserting the company is in default because the maturity date passed without repayment, demanding $1,014,675 inclusive of principal, accrued interest, and a 20% default-related increase. The company is evaluating the implications of the default notice and is in active discussions with the lender, a development that could impact its liquidity position and near-term financial flexibility.
More about GridAI Technologies
GridAI Technologies Corp., formerly known as Entero Therapeutics, Inc., is a publicly listed company that has transitioned from its prior identity in the therapeutics sector and now operates under a technology-focused brand. The company engages in financing arrangements such as revolving loan facilities to support its corporate activities and working capital needs within its evolving business strategy.
Average Trading Volume: 118,020
Technical Sentiment Signal: Sell
Current Market Cap: $7.63M
For detailed information about GRDX stock, go to TipRanks’ Stock Analysis page.